LIPOCINE INC. Cash and Cash Equivalents, Period Increase (Decrease)
LIPOCINE INC. (LPCN) reported Cash and Cash Equivalents, Period Increase (Decrease) of $144.56 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-08
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $144.56K, a 97.30% decline year-over-year.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $5.35M, a 288.91% increase year-over-year.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$6.06M, a 809.55% decline year-over-year.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$7.36M.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $9.87M.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$2.35M.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$14.45M.
- LIPOCINE INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$7.66M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 15 month | Cash and Cash Equivalents, Period Increase (Decrease) 18 month | Cash and Cash Equivalents, Period Increase (Decrease) 21 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $144.56K 10-Q · filed 2019-05-08 | ||||||||||
| 2018-12-31 | $9.87M 10-K · filed 2019-03-06 | ||||||||||
| 2018-03-31 | $5.35M 10-Q · filed 2019-05-08 | -$709.51K derived: sum of 2 quarters · filed 2019-05-08 | -$8.07M derived: sum of 3 quarters · filed 2019-05-08 | $1.62M derived: sum of 4 quarters · filed 2019-05-08 | |||||||
| 2017-12-31 | -$6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$13.42M derived: sum of 2 quarters · filed 2019-03-06 | -$3.73M derived: sum of 3 quarters · filed 2019-03-06 | -$2.35M 10-K · filed 2019-03-06 | |||||||
| 2017-09-30 | -$7.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $2.33M derived: sum of 2 quarters · filed 2017-11-08 | $3.71M 10-Q · filed 2017-11-08 | $4.56M derived: sum of 4 quarters · filed 2019-03-06 | |||||||
| 2017-06-30 | $9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $11.07M 10-Q · filed 2017-08-07 | $11.92M derived: sum of 3 quarters · filed 2019-03-06 | $4.26M derived: sum of 4 quarters · filed 2019-03-06 | |||||||
| 2017-03-31 | $1.38M 10-Q · filed 2018-05-07 | $2.23M derived: sum of 2 quarters · filed 2019-03-06 | -$5.44M derived: sum of 3 quarters · filed 2019-03-06 | -$7.18M derived: sum of 4 quarters · filed 2019-03-06 | |||||||
| 2016-12-31 | $854.08K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$6.81M derived: sum of 2 quarters · filed 2019-03-06 | -$8.55M derived: sum of 3 quarters · filed 2019-03-06 | -$14.45M 10-K · filed 2019-03-06 | |||||||
| 2016-09-30 | -$7.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$9.41M derived: sum of 2 quarters · filed 2017-11-08 | -$15.30M 10-Q · filed 2017-11-08 | -$19.22M derived: sum of 4 quarters · filed 2018-03-12 | |||||||
| 2016-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$7.63M 10-Q · filed 2017-08-07 | -$11.55M derived: sum of 3 quarters · filed 2018-03-12 | -$25.92M derived: sum of 4 quarters · filed 2018-03-12 | |||||||
| 2016-03-31 | -$5.89M 10-Q · filed 2017-05-08 | -$9.81M derived: sum of 2 quarters · filed 2018-03-12 | -$24.18M derived: sum of 3 quarters · filed 2018-03-12 | -$10.65M derived: sum of 4 quarters · filed 2018-03-12 | |||||||
| 2015-12-31 | -$3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$18.29M derived: sum of 2 quarters · filed 2018-03-12 | -$4.76M derived: sum of 3 quarters · filed 2018-03-12 | -$7.66M 10-K · filed 2018-03-12 | |||||||
| 2015-09-30 | -$14.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$838.92K derived: sum of 2 quarters · filed 2016-11-08 | -$3.74M 10-Q · filed 2016-11-08 | -$7.74M derived: sum of 4 quarters · filed 2017-03-06 | |||||||
| 2015-06-30 | $13.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $10.63M 10-Q · filed 2016-08-09 | $10.63M 10-Q · filed 2015-08-11 | $6.63M derived: sum of 3 quarters · filed 2017-03-06 | $4.13M derived: sum of 4 quarters · filed 2017-03-06 | ||||||
| 2015-03-31 | -$2.90M 10-Q · filed 2016-05-09 | -$6.90M derived: sum of 2 quarters · filed 2017-03-06 | -$9.40M derived: sum of 3 quarters · filed 2017-03-06 | -$17.01M derived: sum of 4 quarters · filed 2017-03-06 | |||||||
| 2014-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$6.50M derived: sum of 2 quarters · filed 2017-03-06 | -$14.11M derived: sum of 3 quarters · filed 2017-03-06 | -$17.60M 10-K · filed 2017-03-06 | |||||||
| 2014-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$10.11M derived: sum of 2 quarters · filed 2015-11-12 | -$13.60M 10-Q · filed 2015-11-12 | -$5.17M derived: sum of 4 quarters · filed 2015-11-12 | |||||||
| 2014-06-30 | -$7.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$11.10M 10-Q · filed 2015-08-11 | -$2.68M derived: sum of 3 quarters · filed 2015-08-11 | $30.56M derived: sum of 4 quarters · filed 2015-08-11 | |||||||
| 2014-03-31 | -$3.49M 10-Q · filed 2015-05-07 | $4.93M derived: sum of 2 quarters · filed 2015-05-07 | $38.17M derived: sum of 3 quarters · filed 2015-05-07 | $37.16M derived: sum of 4 quarters · filed 2015-05-07 | |||||||
| 2013-12-31 | $8.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $41.66M derived: sum of 2 quarters · filed 2015-03-11 | $40.65M derived: sum of 3 quarters · filed 2015-03-11 | $39.89M 10-K · filed 2015-03-11 | |||||||
| 2013-09-30 | $33.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $32.22M derived: sum of 2 quarters · filed 2014-11-10 | $31.46M 10-Q · filed 2014-11-10 | $30.42M derived: sum of 4 quarters · filed 2014-11-10 | |||||||
| 2013-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$1.77M 10-Q · filed 2014-08-13 | -$567.00 10-Q · filed 2013-07-09 | -$2.81M derived: sum of 3 quarters · filed 2014-08-13 | -$4.94M derived: sum of 4 quarters · filed 2014-08-13 | $10.00 10-Q · filed 2013-07-09 | |||||
| 2013-03-31 | -$759.44K 10-Q · filed 2014-05-13 | -$119.00 10-Q · filed 2013-04-24 | -$1.80M derived: sum of 2 quarters · filed 2014-05-13 | -$3.93M derived: sum of 3 quarters · filed 2014-05-13 | -$3.95M derived: sum of 4 quarters · filed 2014-05-13 | $458.00 10-Q · filed 2013-04-24 | |||||
| 2012-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$3.17M derived: sum of 2 quarters · filed 2014-03-31 | -$3.19M derived: sum of 3 quarters · filed 2014-03-31 | -$3.19M 10-K · filed 2014-03-31 | -$22.37K 10-K · filed 2013-02-26 | $577.00 10-K · filed 2013-02-26 | |||||
| 2012-09-30 | -$2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$2.15M derived: sum of 2 quarters · filed 2013-11-13 | -$2.15M 10-Q · filed 2013-11-13 | -$22.32K 10-Q · filed 2012-10-26 | $622.00 10-Q · filed 2012-10-26 | ||||||
| 2012-06-30 | -$14.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09 | -$19.51K 10-Q · filed 2013-07-09 | $3.43K derived: sum of 3 quarters · filed 2013-07-09 | ||||||||
| 2012-03-31 | -$5.05K 10-Q · filed 2013-04-24 | $17.89K derived: sum of 2 quarters · filed 2013-04-24 | |||||||||
| 2011-12-31 | $22.94K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $22.94K 10-K · filed 2013-02-26 | |||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |